Nextech Invest Ag Mersana Therapeutics, Inc. Transaction History
Nextech Invest Ag
- $530 Million
- Q2 2024
A detailed history of Nextech Invest Ag transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Nextech Invest Ag holds 9,526,146 shares of MRSN stock, worth $19.4 Million. This represents 3.61% of its overall portfolio holdings.
Number of Shares
9,526,146
Previous 3,856,321
147.03%
Holding current value
$19.4 Million
Previous $17.3 Million
10.83%
% of portfolio
3.61%
Previous 3.23%
Shares
3 transactions
Others Institutions Holding MRSN
# of Institutions
124Shares Held
114MCall Options Held
73.5KPut Options Held
46.4K-
Eco R1 Capital, LLC San Francisco, CA19.4MShares$39.5 Million1.38% of portfolio
-
Vr Adviser, LLC New York, NY11.3MShares$23.1 Million2.5% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$17.7 Million3.56% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$17.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$13.7 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $198M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...